Occudo Quantitative Strategies LP Acadia Pharmaceuticals Inc Transaction History

Occudo Quantitative Strategies LP

  • $501 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$20.78 - $31.77 $504,289 - $770,994
24,268 New
24,268 $759,000
Q4 2021

Feb 14, 2022
SELL
$16.79 - $27.09 $243,622 - $393,075
-14,510 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$15.78 - $24.77 $228,967 - $359,412
14,510 New
14,510 $241,000

Others Institutions Holding ACAD

# of Institutions
279
Shares Held
156M
Call Options Held
901K
Put Options Held
314K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email